<?xml version="1.0" encoding="UTF-8"?>
<ref id="b88-dic-2020-4-15">
 <label>88</label>
 <element-citation publication-type="webpage">
  <collab>Takeda Pharmaceutical Company Limited</collab>
  <source>Global plasma leaders collaborate to accelerate development of potential COVID-19 hyperimmune therapy</source>
  <comment>
   <ext-link ext-link-type="uri" xlink:href="https://www.takeda.com/newsroom/newsreleases/2020/global-plasma-leaders-collaborate-to-accelerate-development-of-potential-covid-19-hyperimmune-therapy/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.takeda.com/newsroom/newsreleases/2020/global-plasma-leaders-collaborate-to-accelerate-development-of-potential-covid-19-hyperimmune-therapy/</ext-link>. Published 2020
  </comment>
  <date-in-citation>Accessed April 17, 2020</date-in-citation>
 </element-citation>
</ref>
